echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Six departments issued documents to strictly control the catalogue of basic drugs for academic promotion of enterprises or adjust it this year!

    Six departments issued documents to strictly control the catalogue of basic drugs for academic promotion of enterprises or adjust it this year!

    • Last Update: 2020-02-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    With the six departments working together, another heavy policy affecting the pharmaceutical industry has come On the evening of February 26, the opinions on Strengthening Drug Administration in medical institutions to promote rational use of drugs (hereinafter referred to as the opinions) formulated by the national health and Health Commission in conjunction with the Ministry of education, the Ministry of finance, the Ministry of human resources and social security, the state medical insurance Bureau and the State Food and drug administration were officially released There are 6 parts in the opinion, which include dynamically adjusting the list of national essential medicines, promoting the formation of the "1+X" drug use mode with the basic drugs as the leading body at all levels, perfecting the drug procurement system, and recording the academic conferences of enterprises, standardizing Internet plus pharmaceutical services, etc Push the 1 + X mode of drug use, or adjust the list of basic drugs this year Since 2009, China has started to implement the national directory of basic drugs Since then, the system of the directory of basic drugs has been continuously improved, and the directory of basic drugs has been constantly adjusted and enriched In 2018, the total varieties of national essential drugs catalogue increased from 520 to 685 Last year, the National Health Insurance Bureau issued a document to abolish the local supplement of basic drugs, marking the unified use of the national basic drug catalog The drugs in the catalogue of basic drugs are the basis for the use of drugs in medical institutions Entering the base drug catalog is equivalent to entering the official purchase list This time, the six departments made sure that the country will dynamically adjust the national essential drug catalogue based on the clinical drug demand All localities should make greater efforts to promote the priority allocation and use of essential drugs, and promote medical institutions at all levels to form a "1 + X" drug use mode dominated by essential drugs "1" is the national essential drug list; "X" is non essential drug In addition, priority should be given to national organizations for centralized purchase and use of drugs and drugs listed in the national medical insurance catalogue According to the previous opinions on further ensuring the supply and price stability of drugs in short supply (GBF [2019] No 47) issued by the general office of the State Council, the proportion of basic drug varieties is not less than 90%, 80% and 60% according to the requirements of primary, secondary and tertiary medical institutions, which is called basic drug 986 by the industry Under such circumstances, a batch of non base drugs will undoubtedly be gradually eliminated, especially those not included in the national centralized procurement and medical insurance catalogue It is worth mentioning that the adjustment principle of base drug catalog before is no more than three years, and the last version is 2018, so it is very likely that the base drug catalog will be readjusted in 2020 In the future, once the dynamic adjustment mechanism is established, the adjustment of the base drug list will be made according to the clinical needs, and the time is no longer limited by three years Recently, the second batch of national centralized drug purchase has been opened, and the majority of patients are expected to use this batch of drugs in April this year It can be seen from many national documents that the national centralized mining system is expected to move from the initial pilot to normalization In this opinion, it is mentioned to improve the drug purchase and supply system of medical institutions and require public medical institutions to do a good job in the centralized purchase and use of drugs In addition, the document mentioned that "relying on the provincial drug centralized procurement platform, actively participate in the construction of a unified and open drug public procurement market." Analysts believe that this means that in the future, all provinces will participate in the centralized procurement work, but at present, there is such a trend, such as the centralized procurement of "two diseases" in Hebei Province, the bulk procurement of drugs without conformity assessment in Fujian Province, the special procurement of antibiotics in Hunan Province, etc with the development of the centralized procurement at the provincial level, new drug price depressions are emerging The mature experience of centralized mining is likely to pave the way for the next step of centralized mining nationwide and gradually form a unified trend In addition, the document encourages medical consortia to explore the unified purchase of drugs and reasonably promote the sharing and use in medical consortia This indicates that in the future, the medical consortia is also expected to achieve unified procurement, and the medical consortia will explore a flexible centralized procurement system and further enrich the mode of centralized procurement Standardize drug promotion and strictly manage pharmacies A long time ago, there was a lot of confusion in the academic promotion of drug consumables The opinions clearly pointed out that "medical institutions should strengthen the management of participating in the academic activities related to the promotion of drug consumables, and the invitations of academic conferences and training projects organized or sponsored by enterprises should be arranged by the medical institutions as a whole, publicized and filed for future reference" This means that policy makers put the standardized drug promotion of medical institutions on the agenda, and some academic conferences and training programs held or sponsored by enterprises will be strictly managed by the hospital, which will fight against corruption to some extent On the other hand, it is mentioned again in the opinion that to adhere to the public welfare nature of pharmacies of public medical institutions, public medical institutions shall not contract or rent pharmacies, shall not trust pharmacies with for-profit enterprises, and shall not open for-profit pharmacies in any form This is also a "commonplace" topic, which shows the decision-makers' determination to prohibit the custody of pharmacies In addition, the opinion also stipulates that enterprises shall not participate in the pharmaceutical management of medical institutions in any form If public medical institutions cooperate with enterprises to carry out logistics extension services, they shall pay relevant fees to enterprises according to the services provided by enterprises This will further crack down on the custody of pharmacies Standardization of online trial, electronic prescription integration supervision, with the development of Internet plus medical health, the industry has discussed the issue of whether to release prescription drugs The difficulty lies in the fact that pharmacists' audit and safety supervision have not yet been improved The state has neither banned the online prescription drugs nor intended to allow them to grow savagely In this opinion, it is mentioned that "to standardize the management of key links in the process of Internet circulation of e-prescription, the audit, deployment and verification personnel of e-prescription must adopt the way of electronic signature or information system trace to ensure the traceability of information" As you can see, online reviewers are further refined in management In addition, the opinion also refers to exploring the interconnection of prescription information and drug retail consumption information of medical and health institutions Strengthen the online and offline integrated supervision of electronic prescriptions Now the company is exploring the prescription circulation platform, and prescription information sharing can further promote online prescription supervision For some non-compliance areas of offline prescriptions, through integrated supervision, it is believed that the prescription information will be more standardized in the future, and online and offline simultaneous supervision of electronic prescriptions is imperative.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.